Company Profile

Tangen Biosciences Inc
Profile last edited on: 9/6/19      CAGE: 6ZYQ1      UEI: K3D1V93LH4F8

Business Identifier: Next generation molecular diagnostics
Year Founded
2013
First Award
2016
Latest Award
2017
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

780 East Main Street Suite 1
Barnford, CT 06405
   (203) 589-0450
   N/A
   jwww.tangenbio.com
Location: Single
Congr. District: 03
County: New Haven

Public Profile

Tangen Bioscience had developed a medical instrument that provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction (PCR) amplification. The device provides rapid nucleic acid detection, in a format that does not require laboratory resources or highly skilled operators. These characteristics enable accurate detection of DNAs of interest directly from patient samples faster, simpler, at greater sensitivity, and at a lower cost than existing commercial technologies, all while being delivered in a portable form factor that does not require a laboratory.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2017 1 NIH $169,001
Project Title: Rapid Detection of multiple sepsis pathogens
2016 1 NIH $216,030
Project Title: Rapid Detection of Multiple Drug resistant TB from Sputum

Key People / Management

  John R Nobile -- Founder, President & Ceo

  Richard Carroll -- VP Business Development and Regulatory Affair

  John F Davidson -- CSO

  Mark Holodniy -- Clinical Research Collaborato

Company News

There are no news available.